Agios Pharmaceuticals
AGIO • NASDAQ • Stock Fundamentals
Agios Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Brian Goff, with a market cap of $1.7B.
Market Cap$1.7B
Employees386.0
CEOBrian Goff
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsApr 29, 2026 · 1 month 16 days agoQ1 2026
View reportNext EarningsJul 30, 2026 · in a monthBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Agios Pharmaceuticals FAQ
Common questions about Agios Pharmaceuticals
Agios Pharmaceuticals (AGIO) has a market capitalization of $1.7B and trades on NASDAQ.
Agios Pharmaceuticals has approximately 386 employees.